Mezoo was established in 2007 in Wonju, Korea. We originally started as an R&D firm that develop wearable Holter, invasive blood glucose algorithm, 3/5/12 lead ECGs, IoMT Platform, and the HiCardi® system. The area of biomedical engineering that we focus on is the development and manufacturing of wearable SmartPatches, mobile, and web-based software. For that, we are committed to developing new Mobile Cardiac Technologies, such as the world’s smallest biosensors, reliable and precise bio-signal measurements. We believe that our innovative remote/real-time/wireless HiCardi system supports medical professionals monitoring and managing patients who suffering from cardiac disorders.